Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype

Alexa A Pragman; Shane W Hodgson; Tianhua Wu; Allison Zank; Cavan S Reilly; Chris H Wendt

doi:10.1183/23120541.00595-2023

Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype

ERJ Open Res. 2024 Feb 5;10(1):00595-2023. doi: 10.1183/23120541.00595-2023. eCollection 2024 Jan.

Authors

Alexa A Pragman¹, Shane W Hodgson², Tianhua Wu³, Allison Zank², Cavan S Reilly³, Chris H Wendt¹

Affiliations

¹ Department of Medicine, Minneapolis VA Health Care System and Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
² Research Service, Minneapolis VA Health Care System, Minneapolis, MN, USA.
³ Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.

Abstract

Background: The lung microbiome is an inflammatory stimulus whose role in COPD pathogenesis is incompletely understood. We hypothesised that the frequent exacerbator phenotype is associated with decreased α-diversity and increased lung inflammation. Our objective was to assess correlations between the frequent exacerbator phenotype, the microbiome and inflammation longitudinally during exacerbation-free periods.

Methods: We conducted a case-control longitudinal observational study of the frequent exacerbator phenotype and characteristics of the airway microbiome. 81 subjects (41 frequent and 40 infrequent exacerbators) provided nasal, oral and sputum microbiome samples at two visits over 2-4 months. Exacerbation phenotype, relevant clinical factors and sputum cytokine values were associated with microbiome findings.

Results: The frequent exacerbator phenotype was associated with lower sputum microbiome α-diversity (p=0.0031). This decrease in α-diversity among frequent exacerbators was enhanced when the sputum bacterial culture was positive (p<0.001). Older age was associated with decreased sputum microbiome α-diversity (p=0.0030). Between-visit β-diversity was increased among frequent exacerbators and those who experienced a COPD exacerbation between visits (p=0.025 and p=0.014, respectively). Sputum cytokine values did not differ based on exacerbation phenotype or other clinical characteristics. Interleukin (IL)-17A was negatively associated with α-diversity, while IL-6 and IL-8 were positively associated with α-diversity (p=0.012, p=0.012 and p=0.0496, respectively). IL-22, IL-17A and IL-5 levels were positively associated with Moraxella abundance (p=0.027, p=0.0014 and p=0.0020, respectively).

Conclusions: Even during exacerbation-free intervals, the COPD frequent exacerbator phenotype is associated with decreased sputum microbiome α-diversity and increased β-diversity. Decreased sputum microbiome α-diversity and Moraxella abundance are associated with lung inflammation.